ALXO
ALX Oncology·NASDAQ
--
--(--)
--
--(--)
3.81 / 10
Netural
Fund-flow sentiment is robust at 7.62/10. Although overall and block trends are negative, Small-cap inflows show a positive trend, and the overwhelmingly bullish analyst consensus (100% Buy) supports liquidity momentum. This mix suggests underlying buying interest despite short-term technical weakness.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-05
InstitutionPiper Sandler
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for ALXO?
- ALXO holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.81/10 (Netural).
